Zachary Roberts
Förmögenhet: 362 938 $ per 2026-07-31
Förmögenhet: 362 938 $ per 2026-07-31
Zachary Roberts is currently President, Chief Executive Officer & Director at Allogene Therapeutics, Inc., starting in 2026.
Formerly, Dr. Roberts was Chief Medical Officer at Instil Bio, Inc. from 2020 to 2022, Vice President-Clinical Development at Kite Pharma, Inc. from 2018 to 2019, and Director-Clinical Medical Research at Amgen, Inc. in 2015.
Education includes undergraduate studies at the University of Maryland and a doctorate from the University of Maryland School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-01 | 193 052 ( 0,06 % ) | 362 938 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Verkställande Direktör | 2026-07-01 |
| Företag | Position | Slut |
|---|---|---|
| INSTIL BIO, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-11-11 |
| KITE PHARMA INC | Teknisk/Vetenskaplig/F&U Direktör | 2019-05-01 |
| AMGEN INC. | Teknisk/Vetenskaplig/F&U Direktör | 2015-07-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland School of Medicine
University of Maryland School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Instil Bio, Inc.
Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån